Hepatoid adenocarcinoma of the stomach with ideal response to neoadjuvant chemo-immunotherapy: a case report
Hepatoid adenocarcinoma of the stomach (HAS) is a rare subtype of gastric cancer characterized by histological features resembling hepatocellular carcinoma. Surgical intervention remains the preferred treatment modality for eligible patients. However, the efficacy of neoadjuvant therapy and alternat...
Saved in:
| Main Authors: | Linchuan Li, Dexu Zhang, Jiankang Zhu, Guangyong Zhang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-01-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2024.1496342/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinicopathological features of hepatoid adenocarcinoma and non‐hepatoid adenocarcinoma of the stomach: A systematic review and meta‐analysis
by: Qi Ling, et al.
Published: (2024-08-01) -
Rare case of primary hepatoid adenocarcinoma of the lung
by: E. A. Toneev, et al.
Published: (2022-05-01) -
Long survival after neoadjuvant and adjuvant camrelizumab plus chemotherapy and surgery in a patient with hepatoid adenocarcinoma of the lung: A case report
by: Xuhua Huang, et al.
Published: (2024-12-01) -
Hepatoid adenocarcinoma of the lung: a rare case report
by: Leyre Alonso Gonzalo, et al.
Published: (2025-07-01) -
Hyperbaric oxygen therapy as an immunosensitizing strategy in advanced gastric hepatoid adenocarcinoma: a case report
by: Wenke Li, et al.
Published: (2025-06-01)